PHARMAZELL INDIA PRIVATE LTD
Overview
PHARMAZELL INDIA PRIVATE LTD is an active pharmaceutical ingredient (API) supplier with 19 active FDA Type II Drug Master Files, covering ABIRATERONE ACETATE; ATAZANAVIR SULPHATE [DRUG SUBSTANCE (NON-STERILE)]; CAPECITABINE USP [DRUG SUBSTANCE (NON-STERILE)]; CELECOXIB USP; DASATINIB; DASATINIB [DRUG SUBSTANCE (NON-STERILE)].
Core services & business areas
Active pharmaceutical ingredients supplied
Substances PHARMAZELL INDIA PRIVATE LTD is evidenced to supply (US FDA Drug Master File or EU CEP). Open any ingredient to see its full supplier landscape, CAS number and patent status.
API / Drug Master Files
PHARMAZELL INDIA PRIVATE LTD holds 1 active (6 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.
- CELECOXIB USPActive2012-08-20
- N-ACETYLTYROSINEInactive2010-05-12
- CLOPIDOGREL BISULFATEInactive2009-03-05
- N-ACETYL TYROSINEInactive2009-02-21
- L-CYSTINEInactive2008-08-14
- ATENOLOL USPInactive2006-07-10
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to PHARMAZELL INDIA PRIVATE LTD in our records. PharmaTek screens the full directory against live FDA enforcement data.
Is this PHARMAZELL INDIA PRIVATE LTD? Get in front of buyers actively sourcing.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.